(Q44120755)

English

Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial.

scientific article published on 26 November 2013

In more languages

Statements

scholarly article

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Efficacy and safety of vildagliptin in new-onset diabetes after kidney transplantation--a randomized, double-blind, placebo-controlled trial (English)

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1 reference

based on heuristic

inferred from title

Johannes Werzowa

2

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Manfred Hecking

3

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

author name string

M Haidinger

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M Antlanger

4

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

G Stemer

5

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

J Pleiner

6

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

C Kopecky

7

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

J J Kovarik

8

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

D Döller

9

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

G Pacini

10

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

M D Säemann

11

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

language of work or name

0 references

publication date

26 November 2013

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

American Journal of Transplantation

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

14

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

1

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

115-123

1 reference

Europe PubMed Central

PubMed publication ID

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:24279801%20AND%20SRC:MED&resulttype=core&format=json

1 March 2020

Complications associated with new-onset diabetes after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

The association of early post-transplant glucose levels with long-term mortality.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Relationship between inpatient hyperglycemia and insulin treatment after kidney transplantation and future new onset diabetes mellitus

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Diabetic complications associated with new-onset diabetes mellitus in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Novel views on new-onset diabetes after transplantation: development, prevention and treatment.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

New-Onset Diabetes After Transplantation 2003 International Consensus Guidelines: an endocrinologist's view.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Glucose metabolism after renal transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Pancreatic β-cell dysfunction and risk of new-onset diabetes after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Early basal insulin therapy decreases new-onset diabetes after renal transplantation.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Vildagliptin and pioglitazone in patients with impaired glucose tolerance after kidney transplantation: a randomized, placebo-controlled clinical trial.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Cancer risk for patients using thiazolidinediones for type 2 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Use of thiazolidinediones and the risk of bladder cancer among people with type 2 diabetes: a meta-analysis

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Use of thiazolidinediones and risk of heart failure in people with type 2 diabetes: a retrospective cohort study

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Effects of thiazolidinediones on bone loss and fracture

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Thiazolidinediones in the treatment of patients with Post-Transplant-Hyperglycemia or new-onset diabetes mellitus after renal transplantation (NODAT) - A new therapeutic option?

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

The duration of sulfonylurea treatment is associated with β-cell dysfunction in patients with type 2 diabetes mellitus.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Sulfonylurea induced beta-cell apoptosis in cultured human islets

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

beta-cell failure in diabetes and preservation by clinical treatment

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

The DPP4 inhibitor linagliptin delays the onset of diabetes and preserves β-cell mass in non-obese diabetic mice

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Effects of saxagliptin and sitagliptin on glycaemic control and pancreatic β-cell mass in a streptozotocin-induced mouse model of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Reduction of both beta cell death and alpha cell proliferation by dipeptidyl peptidase-4 inhibition in a streptozotocin-induced model of diabetes in mice.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Cardiovascular effects of gliptins

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

GLP-1 receptor activation and Epac2 link atrial natriuretic peptide secretion to control of blood pressure

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Changes in prandial glucagon levels after a 2-year treatment with vildagliptin or glimepiride in patients with type 2 diabetes inadequately controlled with metformin monotherapy

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Dexamethasone induces cell death in insulin-secreting cells, an effect reversed by exendin-4.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Efficacy and safety of vildagliptin monotherapy during 2-year treatment of drug-naïve patients with type 2 diabetes: comparison with metformin

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Efficacy and tolerability of vildagliptin monotherapy in drug-naïve patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Vildagliptin: clinical trials programme in monotherapy and combination therapy for type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Efficacy and safety of sitagliptin versus glipizide in patients with type 2 diabetes and moderate-to-severe chronic renal insufficiency

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Does the new American Diabetes Association definition for impaired fasting glucose improve its ability to predict type 2 diabetes mellitus in Spanish persons? The Asturias Study

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

A randomized, placebo-controlled, double-blind, prospective trial to evaluate the effect of vildagliptin in new-onset diabetes mellitus after kidney transplantation

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Nutrition recommendations and interventions for diabetes: a position statement of the American Diabetes Association

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Methods for clinical assessment of insulin sensitivity and beta-cell function

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Improved meal-related insulin processing contributes to the enhancement of B-cell function by the DPP-4 inhibitor vildagliptin in patients with type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Screening for new-onset diabetes after kidney transplantation: limitations of fasting glucose and advantages of afternoon glucose and glycated hemoglobin

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Vildagliptin preserves the mass and function of pancreatic β cells via the developmental regulation and suppression of oxidative and endoplasmic reticulum stress in a mouse model of diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Safety of dipeptidyl peptidase 4 inhibitors for treatment of type 2 diabetes

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Antidiabetic gliptins in combination with G-CSF enhances myocardial function and survival after acute myocardial infarction.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Pancreatitis, pancreatic, and thyroid cancer with glucagon-like peptide-1-based therapies

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Marked expansion of exocrine and endocrine pancreas with incretin therapy in humans with increased exocrine pancreas dysplasia and the potential for glucagon-producing neuroendocrine tumors

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

The safety of incretin-based therapies--review of the scientific evidence

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Exercise training in solid organ transplant recipients: a systematic review and meta-analysis.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Physical training effects in renal transplant recipients

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Influence of lifestyle modification in renal transplant recipients with postprandial hyperglycemia

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

The use of oral glucose tolerance tests to risk stratify for new-onset diabetes after transplantation: An underdiagnosed phenomenon.

1 reference

https://api.crossref.org/works/10.1111%2FAJT.12518

21 January 2018

Identifiers

Sitelinks

Wikipedia(0 entries)

Wikibooks(0 entries)

Wikinews(0 entries)

Wikiquote(0 entries)

Wikisource(0 entries)

Wikiversity(0 entries)

Wikivoyage(0 entries)

Wiktionary(0 entries)

Multilingual sites(0 entries)

Retrieved from "https://www.wikidata.org/w/index.php?title=Q44120755&oldid=2106793566"